Cargando…
Oral Bicarbonate Therapy in Non-Haemodialysis Dependent Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Metabolic acidosis is a common complication in chronic kidney disease (CKD) patients, and is associated with an accelerated decline in renal function. Oral bicarbonate therapy has been used to counteract metabolic acidosis in CKD for decades. However, until recently, there have been very few interve...
Autores principales: | Hu, May Khei, Witham, Miles D., Soiza, Roy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406285/ https://www.ncbi.nlm.nih.gov/pubmed/30736428 http://dx.doi.org/10.3390/jcm8020208 |
Ejemplares similares
-
Oral sodium bicarbonate in people on haemodialysis: a randomised controlled trial
por: Kourtellidou, Stella I., et al.
Publicado: (2021) -
Does oral sodium bicarbonate therapy improve function and quality of life in older patients with chronic kidney disease and low-grade acidosis (the BiCARB trial)? Study protocol for a randomized controlled trial
por: Witham, Miles D., et al.
Publicado: (2015) -
Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids
por: Gabutti, Luca, et al.
Publicado: (2009) -
The Effects of Oral Sodium Bicarbonate on Renal Function and Cardiovascular Risk in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis
por: Cheng, Fang, et al.
Publicado: (2021) -
Differential effects of phosphate binders on pre-dialysis serum bicarbonate in end-stage kidney disease patients on maintenance haemodialysis
por: Thet, Zaw, et al.
Publicado: (2013)